World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
20706
World Ranking
2569
National Ranking
193

Overview

Schlomo Staszewski is affiliated with Goethe University Frankfurt in Germany. Their research focuses primarily on medicine, with particular emphasis on infectious diseases and virology. The scientist's academic contributions span topics related to HIV research and treatment, including HIV/AIDS research and interventions as well as drug development for HIV/AIDS.

The scientist's work has been published in several venues, with notable contributions to the Journal of Antimicrobial Chemotherapy. Among their recent publications is the 2021 paper titled "2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings", published in the Journal of Antimicrobial Chemotherapy.

Frequent co-authors collaborating with Schlomo Staszewski include:

  • Carlo Torti
  • Robin Wood
  • Dolphina Cogill
  • Hugo Tempelman
  • Raph L Hamers

These collaborations indicate a research network involved in infectious disease and HIV-related studies, integrating expertise from multiple researchers. The scientist's publication record aligns closely with their disciplinary focuses on immunology, microbiology, and infectious diseases.

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

    Joel E. Gallant;Schlomo Staszewski;Anton L. Pozniak;Edwin DeJesus

  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

    R Hogg;V Lima;J Sterne;S Grabar

  • Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

    Schlomo Staszewski;Javier Morales-Ramirez;Karen T. Tashima;Anita Rachlis

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

    Kurt Hertogs;Marie-Pierre de Béthune;Veronica Miller;Tania Ivens

  • Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

    Gerd Fätkenheuer;Anton L Pozniak;Margaret A Johnson;Andreas Plettenberg

  • The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

    Joseph Eron;Patrick Yeni;Joseph Gathe;Vicente Estrada

  • HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

    Andrew N. Phillips;Schlomo Staszewski;Rainer Weber;Ole Kirk

  • Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

    Schlomo Staszewski;Philip Keiser;Julio Montaner;Francois Raffi

  • Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

    G Chêne;J A C Sterne;M May;D Costagliola

  • HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

    May Mt;Sterne Ja;Costagliola D;Sabin Ca

  • Chronic renal failure among HIV-1-infected patients

    Amanda Mocroft;Ole Kirk;Jose Gatell;Peter Reiss

  • Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

    Veronica Miller;Caroline Sabin;Kurt Hertogs;Stuart Bloor

  • Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America

    E. Girardi;C.A. Sabin;A. d'Arminio Monforte;B. Hogg

  • Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.

    M.W. Lorenz;C. Stephan;A. Harmjanz;S. Staszewski

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

    K. Hertogs;S. Bloor;S. D. Kemp;C. van den Eynde

  • Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naïve HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study

    Hassane Izzedine;Jean Sebastien Hulot;Daniel Vittecoq;Joel E. Gallant

  • Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients : A randomized controlled comparison with zidovudine monotherapy

    Christine Katlama;Didier Ingrand;Clive Loveday;Nathan Clumeck

Frequent Co-Authors

Andrew N. Phillips
Andrew N. Phillips University College London
Veronica Miller
Veronica Miller University of California, Berkeley
Caroline Sabin
Caroline Sabin University College London
Christine Katlama
Christine Katlama Sorbonne University
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Margaret Johnson
Margaret Johnson The Royal Free Hospital
Peter Reiss
Peter Reiss University of Amsterdam
José M. Gatell
José M. Gatell University of Barcelona
Bruno Ledergerber
Bruno Ledergerber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various healthcare and biomedical fields, many of which now offer flexible online programs. For those interested in blending healthcare with information technology, pursuing an online cahiim accredited health information management degree can provide essential skills to manage patient data securely and efficiently.

Career prospects in health information management are promising, with competitive health information manager salary packages reflecting the critical role these professionals play in healthcare systems. Alternatively, students seeking quicker entry into the medical administration field might consider an medical billing and coding certificate online accelerated program, which offers streamlined training for essential medical billing skills.

For those exploring broader medical education options, it's worth researching what medical degree can i get online, as online pathways continue to expand in scope and availability, making healthcare education more accessible than ever.

Overall, these related online degrees complement a background in microbiology by equipping students with versatile skills in healthcare data management, administration, and clinical knowledge, paving the way for diverse career pathways.

Best Scientists Citing Schlomo Staszewski

Trending Scientists